Paxlovid doesn't cut risk of long COVID, study finds
The antiviral drug Paxlovid is great at treating COVID-19 infections, but a new study casts doubt on its effectiveness at preventing symptoms associated with long COVID.
More from Washington Non-Local Sources
NY Times on Washington
New Round of 'No Kings' Rallies Focuses on Getting Out the Vote
Washington Non-Local Sources
•
16h ago
NY Times on Washington
Bruiser the Elk Left His Herd for a Washington Island and Made It Home
Washington Non-Local Sources
•
3d ago
NY Times on Washington
5 Bike Ride Trails in the U.S. That You'll Really Love
Washington Non-Local Sources
•
5d ago
NY Times on Washington
F.B.I. Charges American in Plot Behind Canada's Tumbler Ridge School Shooting
Washington Non-Local Sources
•
Oct 7, 2026
NY Times on Washington
Visiting Llamas and Alpacas at 5 Farms
Washington Non-Local Sources
•
Oct 6, 2026
NY Times on Washington
After a Failed Execution, Scrutiny of the 5 Methods Used to Kill
Washington Non-Local Sources
•
Oct 6, 2026
NY Times on Washington
Mayors Are Filming Videos, Mamdani Style, With Varying Degrees of Cringe
Washington Non-Local Sources
•
Oct 5, 2026
NY Times on Washington
On Breakroom Chronicles, Safeway Workers Serve Nostalgia During Their Lunch Break
Washington Non-Local Sources
•
Sep 30, 2026